Non-alcoholic fatty liver disease is a global health crisis affecting 30% of the population.  The numbers are alarming but not surprising. Fatty liver disease is often asymptomatic with diagnostic tests that are invasive, costly or inaccurate, making early detection challenging ━ until now.

INTRODUCING VELACUR™

The first in-office liver assessment tool with 3D S-WAVE technology. Combining elements of MRE, shear wave ultrasound, and liver visualization to provide real-time quantification of liver stiffness and attenuation.

WATCH A VELACUR PROCEDURE

DON'T WAIT FOR YOUR PATIENTS TO END UP IN THE ER.

TRANSFORM YOUR PRACTICE TODAY WITH VELACUR.